|Bid||6.55 x 800|
|Ask||6.63 x 1400|
|Day's Range||6.52 - 6.70|
|52 Week Range||4.99 - 8.39|
|Beta (3Y Monthly)||1.22|
|PE Ratio (TTM)||12.74|
|Earnings Date||Aug 6, 2019 - Aug 12, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||11.19|
This year has brought a flurry of high-profile IPOs, but the new stocks have hit the market with mixed returns for early investors. Beyond Meat Inc (NASDAQ: BYND ) is up more than 500% from its IPO price ...
On a per-share basis, the San Francisco-based company said it had net income of 75 cents. Earnings, adjusted for investment gains, came to 3 cents per share. The investment fund posted revenue of $227,300 ...
SAN FRANCISCO, May 08, 2019 -- GSV Capital Corp. (“GSV Capital” or the “Company”) (Nasdaq:GSVC) today announced financial results for the quarter ended March 31, 2019. Net.
SAN FRANCISCO, May 02, 2019 -- GSV Capital Corp. (“GSV Capital”) (Nasdaq:GSVC) today announced that it will report its financial results for the quarter ended March 31, 2019.
GSV Capital Corp. (“GSV Capital” or the “Company”) (GSVC) announced today that on April 18, 2019 the Company filed its annual report on Form 10-K for the fiscal year ended December 31, 2018 (the “Form 10-K”). As previously reported, the Company was unable to file the Form 10-K within the prescribed time period without unreasonable effort or expense because the Company’s independent directors retained independent counsel to conduct a review of certain operational and administrative activities of the Company (the “Internal Review”). In addition, as a result of filing the Form 10-K, the Company received a notice from Nasdaq on April 18, 2019 stating that the Company is now in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission.
As previously reported by the Company in its Form 12b-25 filed with the Securities and Exchange Commission (“SEC”) on March 18, 2019 (the “Form 12b-25”), the Company was unable to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2018 (the “Form 10-K”) within the prescribed time period without unreasonable effort or expense because the Company’s independent directors retained independent counsel to conduct a review of certain operational and administrative activities (the “Internal Review”). Today, the Company announced that it received a notice (the “Notice”) on April 2, 2019 from the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) related to the delayed filing of the Form 10-K. The Notice states that, as a result of not having timely filed the Form 10-K, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic financial reports with the SEC. The Notice has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market.
Early investors often make the biggest profits. How? By investing in small companies -- before they strike it big, explains growth stock expert Ian Wyatt, editor of Million Dollar Portfolio.
Thursday, in an interview with CNBC's Becky Quick, Warren Buffett shared that not only hasn't he bought an IPO since 1955, but he can find something better to invest in than Friday's from ride-sharing service company Lyft Inc. No. Buffett's portfolio is not one that is heavy on technology or tech service companies, and odds are he sees somewhat low-entry barriers. alter their business models toward on-demand autonomous cars.
Vireo Health (CSE:VREO), which owns Minneapolis-based medical marijuana producer Minnesota Medical Solutions, went public March 20 through a reverse takeover with a Canadian company listed on the Canadian Securities Exchange. Vireo Health stock currently trades around CAD$5.80. Should you consider buying VREO stock? Source: Shutterstock InvestorPlace - Stock Market News, Stock Advice & Trading TipsWell, I hadn't heard of the company before my editor asked me to write something about it, so I did a little quick research. What I found seemed attractive enough. However, it was another company's investment in Vireo that caught my eye. Why?Private investments, whether we're talking about cannabis or any other industry, have become hot commodities. Publicly-listed companies are disappearing in droves. According to a 2018 study by the Harvard Kennedy School, the U.S. saw the number of public companies shrink by 48% from 8,090 in 1996 to 4,331, 20 years later. * 7 Mid-Cap Growth Stocks That Could Be the Next Amazon or Netflix For various reasons, private companies are opting to wait before taking the IPO plunge. Yes, we are witnessing a surge in unicorn IPOs right now, but that might indicate we are getting to the end of the business cycle; companies want to strike while the iron's hot. To help remedy the situation, the SEC and state securities regulators are overhauling regulations so retail investors like you and I can invest in private companies, formerly the domain of high-net-worth accredited investors, pension funds, and other large institutional investment funds. Soon, investing in private companies will be as easy as sending money to a friend over your smartphone. In the meantime, there are some exciting options available. First, let's start with the company I mentioned owned a piece of Vireo Health.Cannabis Growth Opportunity: Based in Toronto and also listed on the Canadian Securities Exchange, Cannabis Growth Opportunity Corp. (CNSX:CGOC) invests in private and public cannabis companies. Currently, its investment portfolio is weighted 60% in private companies, 37% in public companies, and 3% in cash. At the end of October, its fiscal year-end, it had assets of CAD$42.2 million. In the case of Vireo, Cannabis Growth initially invested $2.0 million in the company in July 2018. Its preferred shares were converted to 1 million common shares through the reverse takeover. Those shares delivered a gain of $3.7 million (188%) in less than a year. I recommend you take a look at its portfolio of investments. CGOC is an excellent way to capture a little of the private capital markets.GSV Capital: Barron's recently covered this Silicon Valley investment fund that owns a piece of Lyft, which is close to going public. GSV Capital (NASDAQ:GSVC) is trading at a 30% discount to its net asset value of $9.89, and Lyft (NASDAQ:LYFT) is the company's seventh-largest holding. Other companies you've probably heard of in its top 10 holdings include Spotify (NYSE:SPOT), Palantir Technologies, Dropbox (NASDAQ:DBX), and Coursera. Unfortunately, it doesn't have any cannabis investments that I'm aware of.Years ago, I recommended GSV's stock because I'd read founder Michael Moe's book, Finding the Next Starbucks: How to Identify and Invest in the Hot Stocks of Tomorrow, and thought the premise of the fund made sense. It's had some ups and downs since then, but given it's focusing a lot more attention on its best ideas, more investments like Lyft are bound to push the stock higher. That said, anytime you invest in private companies, you're flying blind. These aren't investments you should be making in a tax-advantaged account. Other Private Equity OptionsAs the cannabis space evolves, more companies like Cannabis Growth will emerge, providing investors with lots of private capital options. In the meantime, I'd suggest you scour the listings of business development companies (BDCs) and private equity firms that invest in private companies that are growing, including those operating in the cannabis industry. A good example is Compass Diversified Holdings (NYSE:CODI), a holding company that invests in middle market companies in North America. In February, CODI sold Manitoba Harvest, the world's largest producer of hemp foods, to Tilray (NASDAQ:TLRY) for CAD$419 million. Compass is probably best known for buying Fox Factory (NASDAQ:FOXF) in 2008 and then spinning it off in 2016, making CODI shareholders approximately $775 million in the process. As of this writing, Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 8 Genomic Testing Stocks That Can Ease the Sting of Theranos * 4 Pot Stocks That Could Be Fizzling Out * 7 Mid-Cap Growth Stocks That Could Be the Next Amazon or Netflix Compare Brokers The post Vireo Health Highlights Attractiveness of Private Cannabis Investments appeared first on InvestorPlace.
Net Asset Value of $9.89 per Share as of December 31, 2018 GSV Capital Transitions to an Internally Managed Fund Structure WOODSIDE, Calif., March 14, 2019 -- GSV Capital.
WOODSIDE, Calif., March 11, 2019 -- GSV Capital Corp. (“GSV Capital”) (Nasdaq:GSVC) today announced that it will report its financial results for the quarter and fiscal year.
NEW YORK, Feb. 04, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Umpqua Holdings Corporation (UMPQ) appears to be a promising bet based on solid organic growth, earnings strength and long-term growth opportunities.
The Woodside, California-based company said it had net income of 2 cents per share. Losses, adjusted for investment gains, came to 19 cents per share. The investment fund posted revenue of $246,400 in ...
Net Asset Value of $10.58 per Share as of September 30, 2018 Board of Directors Approves Additional $5.0 Million for Share Repurchase Program, Bringing Share Repurchase Program.
WOODSIDE, Calif., Oct. 31, 2018 -- GSV Capital Corp. (“GSV Capital”) (Nasdaq:GSVC) today announced that it will report its financial results for the quarter ended September 30,.
The Woodside, California-based company said it had profit of 35 cents per share. Losses, adjusted for investment gains, were 14 cents per share. The investment fund posted revenue of $592,100 in the period. ...